Is Resgen overvalued or undervalued?
2025-11-19 08:12:10As of 18 November 2025, the valuation grade for Resgen has moved from fair to very attractive, indicating a significant improvement in its valuation outlook. The company is currently assessed as undervalued. Key ratios supporting this assessment include a PE ratio of 20.29, an EV to EBITDA ratio of 10.32, and a PEG ratio of 0.95, all of which suggest that Resgen is priced favorably compared to its earnings growth potential. In comparison to its peers, Resgen's valuation metrics stand out. For instance, Larsen & Toubro has a much higher PE ratio of 34.3, and CG Power & Industries is deemed very expensive with a PE of 108.1. This places Resgen in a more attractive position relative to its industry, particularly given its solid ROCE of 20.21% and ROE of 12.95%. Despite recent stock performance lagging behind the Sensex, with a year-to-date decline of 33.99% compared to the Sensex's gain of 8.36%, the underlyi...
Read MoreHow has been the historical performance of Resgen?
2025-11-15 00:28:42Answer: The historical performance of Resgen shows significant growth in net sales and profitability over the years, particularly from March 2021 to March 2025. Breakdown: Resgen's net sales have increased dramatically from 0.02 crore in March 2021 to 65.16 crore in March 2025, reflecting a strong upward trend. Total operating income followed a similar trajectory, rising from 0.02 crore in March 2021 to 65.16 crore in March 2025. The company's total expenditure also grew, from 0.01 crore in March 2021 to 49.78 crore in March 2025, with raw material costs being the largest component. Operating profit (PBDIT) has shown consistent improvement, reaching 15.38 crore in March 2025, up from just 0.01 crore in March 2021. Profit before tax increased from 0.01 crore in March 2021 to 11.14 crore in March 2025, and profit after tax rose to 7.98 crore in March 2025 from 0.01 crore in March 2021. The company's total as...
Read MoreWhen is the next results date for Resgen?
2025-11-11 23:20:42The next results date for Resgen is scheduled for 14 November 2025....
Read MoreWhy is Resgen falling/rising?
2025-10-25 00:03:16As of 24-Oct, Resgen Ltd's stock price is currently at 84.00, reflecting an increase of 4.78, or 6.03%. The stock has shown a positive performance today, outperforming its sector by 6.04% and reversing a trend after two consecutive days of decline. It reached an intraday high of Rs 88, marking an 11.08% increase. Despite this positive movement, the stock has experienced a decline of 5.34% over the past month and a significant drop of 28.17% year-to-date. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 54.02% compared to the five-day average, indicating potential concerns among investors. Unfortunately, the positive and negative factors dashboard is not available for further insights. Broader Market Context: In the short term, Resgen's stock has outperformed the benchmark Sensex, which has only increased by 0.31% over the past week, while Resgen has...
Read MoreWhy is Resgen falling/rising?
2025-10-16 00:00:12As of 15-Oct, Resgen Ltd's stock price is currently at 81.50, reflecting a decline of 1.12, or 1.36%. The stock has been underperforming, having fallen consecutively for the last five days, with a total return of -5.66% over that period. Today's performance indicates that the stock has underperformed its sector by 2.83%. Additionally, it reached an intraday low of Rs 79, which represents a drop of 4.38%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Although there has been a rise in investor participation, with delivery volume increasing by 22.45% against the 5-day average, the overall sentiment remains negative, and no positive factors are noted to counterbalance the stock's decline. Broader market context shows that Resgen's performance has significantly lagged behind the benchmark, with a 1-week return of -5.66% compared to the Se...
Read MoreOutcome Of Board Meeting Held For Consideration And Approval Of The Unaudited Financial Results For The Half Year Ended 30Th September 2025
14-Nov-2025 | Source : BSEApproval of the unaudited Financial Results for the half year ended on 30th September 2025
Board Meeting Outcome for Outcome Of Board Meeting Held For Consideration And Approval Of The Unaudited Financial Results For The Half Year Ended 30Th September 2025
14-Nov-2025 | Source : BSEOutcome of Board Meeting held for consideration and approval of the unaudited Financial Results for the half year ended 30th September 2025
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Half Year Ended 30Th September 2025 And Other Matters.
10-Nov-2025 | Source : BSEResgen Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve The unaudited Financial Results for the half year ended 30th September 2025 and other matters.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






